KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells

Blood. 2009 Jun 25;113(26):6619-28. doi: 10.1182/blood-2009-01-199588. Epub 2009 Apr 30.

Abstract

Highly differentiated CD8+CD28-CD27- T cells have short telomeres, defective telomerase activity, and reduced capacity for proliferation, indicating that they are close to replicative senescence. In addition, these cells express increased levels of the senescence-associated inhibitory receptor KLRG1 and have poor capacity for IL-2 synthesis and defective Akt (ser(473)) phosphorylation after activation. It is not known whether signaling via KLRG1 contributes to any of the attenuated differentiation-related functional changes in CD8+ T cells. To address this, we blocked KLRG1 signaling during T-cell receptor activation using antibodies against its major ligand, E-cadherin. This resulted in a significant enhancement of Akt (ser(473)) phosphorylation and T-cell receptor-induced proliferative activity of CD8+CD28-CD27- T cells. Furthermore, the increase of proliferation was directly linked to the Akt-mediated induction of cyclin D and E and reduction in the cyclin inhibitor p27 expression. In contrast, the reduced telomerase activity in highly differentiated CD8+CD28(-)CD27- T cells was not altered by KLRG1 blockade, indicating the involvement of other mechanisms. This is the first demonstration of a functional role for KLRG1 in primary human CD8+ T cells and highlights that certain functional defects that arise during progressive T-cell differentiation toward replicative senescence are maintained actively by inhibitory receptor signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aging / immunology*
  • CD28 Antigens / analysis
  • CD8-Positive T-Lymphocytes / cytology
  • CD8-Positive T-Lymphocytes / enzymology
  • CD8-Positive T-Lymphocytes / immunology*
  • Cadherins / antagonists & inhibitors
  • Cell Differentiation
  • Cellular Senescence
  • Cyclin D2
  • Cyclin E / biosynthesis
  • Cyclin E / genetics
  • Cyclin-Dependent Kinase Inhibitor p27 / biosynthesis
  • Cyclin-Dependent Kinase Inhibitor p27 / genetics
  • Cyclins / biosynthesis
  • Cyclins / genetics
  • Female
  • Humans
  • Lectins, C-Type / antagonists & inhibitors
  • Lectins, C-Type / physiology*
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Phosphoserine / analysis
  • Protein Processing, Post-Translational*
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Receptors, Immunologic
  • Telomere / ultrastructure
  • Trans-Activators / antagonists & inhibitors
  • Trans-Activators / physiology*
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / analysis
  • Young Adult

Substances

  • CCND2 protein, human
  • CD28 Antigens
  • Cadherins
  • Cyclin D2
  • Cyclin E
  • Cyclins
  • KLRG1 protein, human
  • Lectins, C-Type
  • Phosphoinositide-3 Kinase Inhibitors
  • Receptors, Immunologic
  • Trans-Activators
  • Tumor Necrosis Factor Receptor Superfamily, Member 7
  • Cyclin-Dependent Kinase Inhibitor p27
  • Phosphoserine
  • AKT1 protein, human
  • Proto-Oncogene Proteins c-akt